MCL
BEAM icon

MWG Caph Ltd’s Beam Therapeutics BEAM Stock Holding History

MWG Caph Ltd’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$35.1M Buy
+1,266,934
New +$32.3M 48.53% 1

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MWG Caph Ltd's BEAM Position: Q4 2025 in Review

MWG Caph Ltd opened a new position in Beam Therapeutics (BEAM) in Q4 2025: 1,266,934 shares worth $35.1M. The stake represents 48.53% of the portfolio and ranks #1 among its holdings.

246 funds tracked by Wall St. Rank hold BEAM as of Q4 2025.

  • MWG Caph Ltd held 1,266,934 shares of Beam Therapeutics worth $35.1M as of Q4 2025.
  • Beam Therapeutics was a new MWG Caph Ltd position in Q4 2025.
  • Beam Therapeutics made up 48.53% of MWG Caph Ltd's portfolio in Q4 2025, its #1 holding.
  • 246 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2025.

Based on MWG Caph Ltd's 13F filing for Q4 2025, filed 17 Feb 2026.